Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Sampson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Clinical Pharmacology|May 22, 2014
Pharmacokinetic studies in infants using minimal-risk study designsJulie Autmizguine, Daniel K Benjamin, P Brian Smith, et al.
Journal of Clinical Pharmacology|September 23, 2022
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development ProgramKirk Chan-Tack, Mario Sampson, Justin Earp, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Clinical Pharmacology|May 22, 2014
Pharmacokinetic studies in infants using minimal-risk study designsJulie Autmizguine, Daniel K Benjamin, P Brian Smith, et al.
Journal of Clinical Pharmacology|September 23, 2022
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development ProgramKirk Chan-Tack, Mario Sampson, Justin Earp, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Pageof 1